Characterization of the human cytochrome P450 enzymes involved in the metabolism of dihydrocodeine

British Journal of Clinical Pharmacology
L C KirkwoodA A Somogyi

Abstract

Using human liver microsomes from donors of the CYP2D6 poor and extensive metabolizer genotypes, the role of individual cytochromes P-450 in the oxidative metabolism of dihydrocodeine was investigated. The kinetics of formation of N- and O-demethylated metabolites, nordihydrocodeine and dihydromorphine, were determined using microsomes from six extensive and one poor metabolizer and the effects of chemical inhibitors selective for individual P-450 enzymes of the 1A, 2A, 2C, 2D, 2E and 3A families and of LKM1 (anti-CYP2D6) antibodies were studied. Nordihydrocodeine was the major metabolite in both poor and extensive metabolizers. Kinetic constants for N-demethylation derived from the single enzyme Michaelis-Menten model did not differ between the two groups. Troleandomycin and erythromycin selectively inhibited N-demethylation in both extensive and poor metabolizers. The CYP3A inducer, alpha-naphthoflavone, increased N-demethylation rates. The kinetics of formation of dihydromorphine in both groups were best described by a single enzyme Michaelis-Menten model although inhibition studies in extensive metabolizers suggested involvement of two enzymes with similar Km values. The kinetic constants for O-demethylation were significan...Continue Reading

Citations

Nov 8, 2002·Pharmacology & Toxicology·Helmut SchmidtUwe Fuhr
Aug 26, 2003·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·D ProjeanJ Ducharme
Sep 6, 2007·European Journal of Clinical Pharmacology·Helmut Schmidt, Jörn Lötsch
Mar 29, 2008·Expert Opinion on Drug Metabolism & Toxicology·Esin KadievSwati Nagar
Oct 30, 2008·European Journal of Clinical Pharmacology·Janet K CollerAndrew A Somogyi
Oct 3, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Britta BonnNeal Castagnoli
Jun 7, 2020·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tom S ChanMitchell E Taub
Nov 14, 2007·Naunyn-Schmiedeberg's Archives of Pharmacology·Shinya KasaiKazutaka Ikeda
Aug 1, 2006·Personalized Medicine·Caroline Flora SamerPierre Dayer
Oct 6, 1999·British Journal of Clinical Pharmacology·S AmmonG Mikus
May 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N ChernyUNKNOWN Expert Working Group of the European Association of Palliative Care Network
Mar 7, 2007·Clinical Pharmacology and Therapeutics·Andrew A SomogyiJanet K Coller
Oct 13, 2009·Clinical Pharmacokinetics·Shu-Feng Zhou
Nov 12, 2009·Clinical Pharmacokinetics·Shu-Feng Zhou
Sep 14, 2006·Pharmacological Reviews·Sharon J Gardiner, Evan J Begg
Jul 23, 2004·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S A BenettonK M McErlane
Apr 16, 2011·Pharmacology·Wojciech Leppert
Jun 12, 2009·Drug Metabolism Reviews·Shu-Feng ZhouBalram Chowbay
Jul 4, 2008·Pharmacogenomics·Victoria RollasonJules Desmeules
May 9, 2002·Drug Metabolism Reviews·Slobodan Rendic
Mar 27, 2007·Journal of Chemical Information and Modeling·Britta KjellanderIsmael Zamora
Mar 5, 2004·British Journal of Clinical Pharmacology·Mark R HutchinsonAndrew A Somogyi
May 20, 1998·Clinical and Experimental Pharmacology & Physiology·L C KirkwoodA A Somogyi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.